|
|
|
Oxford Global, San Diego, USA
9 - 10 October 2017
Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions. 4 Interactive Streams: - Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
- Successful Phenotypic Drug Discovery: High Content Screening
- Discovery Chemistry: Medicinal and Computational Chemistry
- Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design
Free Webinar Recording: Advance in Fragmented-based Drug Discovery Hosted by Vincent Stoll, Associate Director of Structural Biology, AbbVie For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
Invited Speakers:
|
|
Confirmed and Reserved Speakers 2017 Include: - Michael Letavic, Scientific Director & Fellow, Janssen
- Mark Hurle, Director, Computational Biology, GlaxoSmithKline
- Adeela Kamal, Senior Director, Therapeutic Area Head for Urology and Translational Research, Ferring
- Florian Puehler, Alliance Manager, Bayer
- Wenqing Yao, Executive Vice President, Discovery Chemistry, Incyte
- Ron Alfa, Vice President, Discovery & Product, Recursion Pharma
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
Registration:
|
|
For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.
|
|
|
|
|
|
|
|